Takashima A - Search Results

1

Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative.

Cohen R, Vernerey D, Bellera C, Meurisse A, Henriques J, Paoletti X, Rousseau B, Alberts S, Aparicio T, Boukovinas I, Gill S, Goldberg RM, Grothey A, Hamaguchi T, Iveson T, Kerr R, Labianca R, Lonardi S, Meyerhardt J, Paul J, Punt CJA, Saltz L, Saunders MP, Schmoll HJ, Shah M, Sobrero A, Souglakos I, Taieb J, Takashima A, Wagner AD, Ychou M, Bonnetain F, Gourgou S, Yoshino T, Yothers G, de Gramont A, Shi Q, André T; ACCENT Group. Cohen R, et al. Among authors: takashima a. Eur J Cancer. 2020 May;130:63-71. doi: 10.1016/j.ejca.2020.02.009. Epub 2020 Mar 12. Eur J Cancer. 2020. PMID: 32172199 Free PMC article.

2

Relationships of insulin-like growth factor-1 receptor and epidermal growth factor receptor expression to clinical outcomes in patients with colorectal cancer.

Takahari D, Yamada Y, Okita NT, Honda T, Hirashima Y, Matsubara J, Takashima A, Kato K, Hamaguchi T, Shirao K, Shimada Y, Shimoda T. Takahari D, et al. Among authors: takashima a. Oncology. 2009;76(1):42-8. doi: 10.1159/000178164. Epub 2008 Nov 26. Oncology. 2009. PMID: 19033715

3

Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer.

Hirashima Y, Yamada Y, Matsubara J, Takahari D, Okita N, Takashima A, Kato K, Hamaguchi T, Shirao K, Shimada Y, Taniguchi H, Shimoda T. Hirashima Y, et al. Among authors: takashima a. Cancer Sci. 2009 Feb;100(2):310-5. doi: 10.1111/j.1349-7006.2008.01020.x. Cancer Sci. 2009. PMID: 19068081 Free PMC article.

4

Combination chemotherapy with cisplatin and irinotecan in patients with adenocarcinoma of the small intestine.

Ono M, Shirao K, Takashima A, Morizane C, Okita N, Takahari D, Hirashima Y, Eguchi-Nakajima T, Kato K, Hamaguchi T, Yamada Y, Shimada Y. Ono M, et al. Among authors: takashima a. Gastric Cancer. 2008;11(4):201-5. doi: 10.1007/s10120-008-0484-5. Epub 2009 Jan 8. Gastric Cancer. 2008. PMID: 19132481

5

Progression-free survival in first-line chemotherapy is a prognostic factor in second-line chemotherapy in patients with advanced gastric cancer.

Hashimoto K, Takashima A, Nagashima K, Okazaki SS, Nakajima TE, Kato K, Hamaguchi T, Yamada Y, Shimada Y. Hashimoto K, et al. Among authors: takashima a. J Cancer Res Clin Oncol. 2010 Jul;136(7):1059-64. doi: 10.1007/s00432-009-0752-8. J Cancer Res Clin Oncol. 2010. PMID: 20037789

6

Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer.

Takahari D, Shimada Y, Takeshita S, Nishitani H, Takashima A, Okita N, Hirashima Y, Kato K, Hamaguchi T, Yamada Y, Shirao K. Takahari D, et al. Among authors: takashima a. Gastric Cancer. 2010 Aug;13(3):186-90. doi: 10.1007/s10120-010-0557-0. Epub 2010 Sep 5. Gastric Cancer. 2010. PMID: 20820988

7

Standard First-Line Chemotherapy for Metastatic Gastric Cancer in Japan Has Met the Global Standard: Evidence From Recent Phase III Trials.

Takashima A, Yamada Y, Nakajima TE, Kato K, Hamaguchi T, Shimada Y. Takashima A, et al. Gastrointest Cancer Res. 2009 Nov;3(6):239-44. Gastrointest Cancer Res. 2009. PMID: 21151427 Free PMC article.

8

A Phase I/II trial of chemoradiotherapy concurrent with S-1 plus mitomycin C in patients with clinical Stage II/III squamous cell carcinoma of anal canal (JCOG0903: SMART-AC).

Takashima A, Shimada Y, Hamaguchi T, Ito Y, Nakano A, Nakamura K, Shibata T, Fukuda H, Moriya Y; Colorectal Cancer Study Group of the Japan Clinical Oncology Group. Takashima A, et al. Jpn J Clin Oncol. 2011 May;41(5):713-7. doi: 10.1093/jjco/hyr028. Epub 2011 Apr 5. Jpn J Clin Oncol. 2011. PMID: 21467080 Clinical Trial.

9

First-line fluorouracil-based chemotherapy for patients with severe peritoneal disseminated gastric cancer.

Iwasa S, Nakajima TE, Nakamura K, Takashima A, Kato K, Hamaguchi T, Yamada Y, Shimada Y. Iwasa S, et al. Among authors: takashima a. Gastric Cancer. 2012 Jan;15(1):21-6. doi: 10.1007/s10120-011-0056-y. Epub 2011 May 15. Gastric Cancer. 2012. PMID: 21573919

10

Impact of adding cisplatin to S-1 in elderly patients with advanced gastric cancer.

Terazawa T, Iwasa S, Takashima A, Nishitani H, Honma Y, Kato K, Hamaguchi T, Yamada Y, Shimada Y. Terazawa T, et al. Among authors: takashima a. J Cancer Res Clin Oncol. 2013 Dec;139(12):2111-6. doi: 10.1007/s00432-013-1537-7. Epub 2013 Oct 16. J Cancer Res Clin Oncol. 2013. PMID: 24129809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

757 results

Search Page

Filters